alpha-synuclein_S2

SELEX S2 Round 03; SELEX S2 Round 04 · 13 runs in PRJEB70964

Organism
Nucleic acid
DNA
Rounds available
R3,R4,R6,R7
Sequences indexed
10,000

Top enriched sequences

More via API →
Sequence Length log2 FC P(active) Class Monotonicity
CCGACAAGCCAGAACGCGTTTACTCCAAGAGCGCA
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:e4da0081edc6
35 11.39 0.96 strong_positive 0.33
GCAGCACAGGTCCTTCAACGCGTTTACACCGCTAC
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:7a3c8d1eafa4
35 11.13 0.47 positive 0.00
CGACCTAGCGTCAACTTTTACTCGAGGCCGCAGTG
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:429e44c52bfc
35 10.81 0.85 strong_positive 0.33
ACACGACAGACCGCAAACGCGTTTACTCGCCGCAC
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:7e7751c4399f
35 10.81 0.21 positive 0.00
CCTACAACGCGTCAACGCTACTAACAAGCCGCTTG
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:7569daea3008
35 10.81 0.58 strong_positive 0.33
AGCCACGCTATCACTTATACCTCCAGCCCACCGCC
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:408482976a7b
35 10.81 0.14 strong_positive 0.33
CGTTAGCAGAAATTTCCACATGATGACTGTCGTTA
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:e41366d301b6
35 10.81 0.96 strong_positive 0.33
CCTACAAGCCCAAAACGCGTTTACTAAACTACCCG
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:4db75cb36ff1
35 10.81 0.53 strong_positive 0.33
CGACCTGGCCAAAACGCGTTTACTCCAATGCGCAC
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:ef89f098a69f
35 10.81 0.46 positive 0.00
ACCAGTTTTGAAGGGGCACGGAAACTTTTTGCGCA
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:f190198af68a
35 10.39 0.96 strong_positive 0.33
ATCGTCGAGGGGGAACGAAAAGCAGTGCTGGTGCG
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:b56a01dc6c15
35 10.39 0.98 strong_positive 0.33
ACGTATTGCGAACCACTTATGGGCCTACACCACCT
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:a09bb4124226
35 10.39 0.20 strong_positive 0.33
CAATGGTAACCGTTTGCTAGATTGGTTGATGCGGA
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:eaa8093c1c6a
35 10.39 0.97 strong_positive 0.33
TAACACCGTAGACAAAAACATCGTCAGCATCACCG
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:f1cdd764df56
35 10.39 0.81 strong_positive 0.33
CAACGCGTTTACCTTCACCTACTCGACTCGGAGTG
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:3d7a11df9d3e
35 10.39 0.53 positive 0.00
TCAGCACTGCCTGTAACTTTGAAATCCCACTACTG
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:e1bc39b4d596
35 10.39 0.34 strong_positive 0.33
GAGCGCATAGTGTGGTCTGGCACACTCCAGAGGAC
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:016196e83c81
35 10.39 0.97 strong_positive 0.33
GTGGATATCGAACACTACCCTTCCATCATCCAGCC
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:6ddcc9875f00
35 10.39 0.73 strong_positive 0.33
AACCGCAAAAGCCCCATAATCCGCACTGGCTAAGC
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:67b1299a62dd
35 10.39 0.97 strong_positive 0.33
AGACGACACAGACCAACGCGTTTACTAAGCGAAC
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:7656f3babfae
34 10.39 0.94 strong_positive 0.33
GTGTAAAACGCGCTAAACTAAACGCACTAGGTCAC
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:b96e06d8ab75
35 10.39 0.97 strong_positive 0.33
AGCCATGCCGACCAACTTATAGCTCTCTCCCAACA
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:e8db2ac27f73
35 10.39 0.21 strong_positive 0.33
GATGCAACGCAGCAGACACTGAAGAAATTTGACGA
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:064a8ebd6a55
35 10.39 0.97 strong_positive 0.33
ATCCGAACAGTCCGCAACTTTGAAATCCCGCTATG
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:867b414d5b19
35 10.39 0.74 strong_positive 0.33
GTCAGCATCAGTGGTCAACGCGTTTACACCACATG
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:9671328d1298
35 10.39 0.25 strong_positive 0.33
GTGTAAGGCAAGGAGTCGAGCTTTGGTCGCGGACA
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:f406f7dc2e32
35 10.39 0.98 strong_positive 0.33
CCAACGGCTGCAACCTCAGGGAAGAGAGGTTCTCA
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:7c50ce08e0cf
35 10.39 0.96 strong_positive 0.33
TCCGCGAATCGCCCTACCGATTTAGAGCCCGCGCG
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:2065382c5501
35 10.39 0.51 strong_positive 0.33
AGAGACCATCAGAACTGTTTGCTCGGCAACTCATC
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:2317c25c3a2a
35 10.39 0.96 strong_positive 0.33
GACGCTAACCAGCTTAAGTCTAGACAGCCATGCGT
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:85d0046e9d01
35 10.39 0.93 strong_positive 0.33
AGCCACGCTTTCAACGTACCAGTACCAAAACGTCG
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:d4cc9fb7e7c4
35 10.39 0.55 strong_positive 0.33
CCTACATAGCCTCTACGCGTTTACACCAAACCTGC
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:6d0c991682cc
35 10.39 0.20 strong_positive 0.33
TGGTAACGACGTTCTAATTACCTACACCCCTCCAC
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:38e5b3a5a48d
35 10.39 0.22 strong_positive 0.33
CTCAGCACAGCCGACAGCGCGTTTACTCCAGACAC
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:2082422f5171
35 10.39 0.26 strong_positive 0.33
AGCCATGCCAAGAGACGTCTACGAGTACCACCGCG
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:669bf5d9207a
35 10.39 0.87 positive 0.00
ACGAAGAGCGATCTCGCCTACATTGCACCCAGCTT
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:c776a2f0931f
35 10.39 0.93 strong_positive 0.33
TGGTATCCAGCAACCGTGTCCTGGAACAACGAGTG
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:e819bbfb9612
35 10.39 0.93 strong_positive 0.33
ATTAGGCAAAGAACCATCACGAGCGCACAAATCGC
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:8f464e926a0e
35 10.39 0.98 strong_positive 0.33
AGTACGAGCAGAGGCGCAACCACCACTAAATCCAA
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:64019646fbd0
35 10.39 0.97 strong_positive 0.33
GTCCATGCAGCTAAGAGCCTACTCTGTGGCAAGCG
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:568d86753280
35 10.39 0.96 strong_positive 0.33
AGCCACGCCTGCAACTTATAGCCTTTCCCCATACA
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:1e842f648c19
35 10.39 0.16 strong_positive 0.33
ATCAGTCCACGACCCAACTTATACCCTCCGACCCG
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:15bc02c96c53
35 10.39 0.16 strong_positive 0.33
ACCTACACGGCCGCAACGCGTTTATTCTCACTGCA
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:b4258b5f76b3
35 10.39 0.14 positive 0.00
TATAGGTTAATTCACGTGCAACATACCGCTTGAAC
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:fe60e915f2fc
35 10.39 0.92 strong_positive 0.33
CGTGGATTGTACAATCACCGCATTTCCGAATGGCC
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:e4780d002b8f
35 10.39 0.96 strong_positive 0.33
ATCAGCACACCTCACTTATACGGTTCCGTGACC
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:ba21a51c5a24
33 10.39 0.23 strong_positive 0.33
CATAGGGGACACCGCGCAAACTTATTAGGGTAATG
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:3d7b42fbc996
35 10.39 0.99 strong_positive 0.33
ACCGATACAGCATTAGCGTTATACTCCACCGCTCG
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:ae22ef7a6a49
35 10.39 0.16 strong_positive 0.33
TTATAATCGGTCAAATCAGCTCTGCGAACCTCGTA
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:47f24775d238
35 10.39 0.83 strong_positive 0.33
GCAAGAGTACACCCGCCGTAGTCGTCTACGGGCTA
PANAPTA:NA:alpha-synuclein_S2:PRJEB70964:R7:c62412df1dcb
35 10.39 0.97 strong_positive 0.33

SELEX rounds

R3 R4 R6 R7 ·final